These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8116184)

  • 1. Statistical methods for analysis of in vitro antigen quantification data for veterinary biologic products.
    Wilbur LA
    Vet Microbiol; 1993 Nov; 37(3-4):231-40. PubMed ID: 8116184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro potency assays for nonreplicating veterinary vaccines: comparison to in vivo assays and considerations in assay development.
    Levings RL; Henderson LM; Metz CA
    Vet Microbiol; 1993 Nov; 37(3-4):201-19. PubMed ID: 8116182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of in vitro potency tests as a measure of vaccine or reference stability.
    Pfannenstiel MA; Inman M
    Dev Biol (Basel); 2012; 134():141-8. PubMed ID: 22888607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency testing of veterinary vaccines for animals: the way from in vivo to in vitro. Workshop summary.
    Dev Biol (Basel); 2012; 134():149-52. PubMed ID: 22888608
    [No Abstract]   [Full Text] [Related]  

  • 5. Design and analysis of veterinary vaccine efficacy trials.
    Tanner JE; Morgan AP
    Vet Microbiol; 1993 Nov; 37(3-4):221-30. PubMed ID: 8116183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antigen measurement and potency tests: challenges encountered during method development...and lessons learned.
    Kubiak V
    Dev Biol (Basel); 2012; 134():83-91. PubMed ID: 22888599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Lack-of-Fit Assessment as a System Suitability Test for Potency Assays.
    Li R; Cai W; Zocher M
    PDA J Pharm Sci Technol; 2017; 71(5):368-378. PubMed ID: 28624777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation study to evaluate the reproducibility of a candidate in vitro potency assay of newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation.
    Claassen I; Maas R; Oei H; Daas A; Milne C
    Pharmeuropa Bio; 2004 Dec; 2004(1):1-15. PubMed ID: 15659281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of non parallel immunoassay curves resulting from mixtures of competing antigens.
    Kaiser MS; Siev D
    Stat Med; 1997 May; 16(10):1151-66. PubMed ID: 9179980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro vaccine potency testing: a proposal for reducing animal use for requalification testing.
    Brown K; Stokes W
    Dev Biol (Basel); 2012; 134():75-81. PubMed ID: 22888598
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kulpa-Eddy J; Srinivas G; Halder M; Hill R; Brown K; Roth J; Draayer H; Galvin J; Claassen I; Gifford G; Woodland R; Doelling V; Jones B; Stokes WS
    Procedia Vaccinol; 2011; 5():60-83. PubMed ID: 32288914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validation of potency tests: hurdles identified by EMA/CVMP/IWP.
    Woodland R
    Dev Biol (Basel); 2012; 134():69-73. PubMed ID: 22888597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study to evaluate the correlation between results of a candidate in vitro assay and established in vivo assays for potency determination of Newcastle disease vaccines.
    Claassen I; Maas R; Daas A; Milne C
    Pharmeuropa Bio; 2003 Jul; 2003(1):51-66. PubMed ID: 14563308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international collaborative study on a method for determination of formaldehyde in veterinary vaccines.
    Ross PF; Draayer H; Itoh O
    Biologicals; 2002 Mar; 30(1):37-41. PubMed ID: 11846428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency testing of veterinary vaccines: the way from in vivo to in vitro.
    Romberg J; Lang S; Balks E; Kamphuis E; Duchow K; Loos D; Rau H; Motitschke A; Jungbäck C
    Biologicals; 2012 Jan; 40(1):100-6. PubMed ID: 22075457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatives to in vivo potency and protection tests for veterinary vaccines.
    Lucken RN
    Dev Biol Stand; 1999; 101():67-72. PubMed ID: 10566777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models.
    Vølund A
    Biometrics; 1978 Sep; 34(3):357-65. PubMed ID: 719119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.